Random Blood Glucose, but Not HbA1c, Was Associated with Mortality in COVID-19 Patients with Type 2 Diabetes Mellitus—A Retrospective Study

• Main Authors: Stefanus Gunawan Kandinata, -, Soebagijo Adi Soelistijo, Soebagijo, Agung Pranoto, -, Erwin Astha Triyono, -
• Format: Article PeerReviewed
• Language: English; Indonesian; English; English
• Published: Multidisciplinary Digital Publishing Institute (MDPI)
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/130958/1/21.%20Artikel.pdf; https://repository.unair.ac.id/130958/2/21%20karil.pdf; https://repository.unair.ac.id/130958/3/21.%20turnitin.pdf; https://repository.unair.ac.id/130958/4/21.%20korespondensi.pdf; https://repository.unair.ac.id/130958/; https://pubmed.ncbi.nlm.nih.gov/37092526/; https://doi.org/10.3390/pathophysiology30020012
• Institution: Universitas Airlangga

Abstract Previous studies have yielded inconsistent results on whether glycated hemoglobin (HbA1c) and random blood glucose (RBG) are associated with mortality of coronavirus disease 2019 (COVID-19) patients with type 2 diabetes mellitus (T2DM). This study aimed to assess the association of HbA1c a...